Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
10.35
+0.23 (2.27%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Immunic Market Cap
Immunic has a market cap or net worth of $141.22 million as of September 17, 2026. Its market cap has increased by 75.65% in one year.
Market Cap
141.22M
Enterprise Value
-13.31M
1-Year Change
75.65%
Ranking
Category
Stock Price
$10.35
ChartMarket Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $141.22M, a decrease of -42.03%. That is a compound annual growth rate of -7.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 141.22M | 119.98% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 151.02M |
| Tenaya Therapeutics | 150.73M |
| Conexeu Sciences | 149.50M |
| Kazia Therapeutics | 148.82M |
| NRx Pharmaceuticals | 146.66M |
| Codexis | 144.55M |
| Neumora Therapeutics | 140.92M |
| Caribou Biosciences | 140.44M |